Covid-19 was the third leading cause of death in the United States last year, after heart disease and cancer, according to provisional data recently released by the US Centers for Disease Control and Prevention.
Covid-19 was the third leading cause of death in the United States last year, after heart disease and cancer, according to provisional data recently released by the US Centers for Disease Control and Prevention.
The death rate from 2019 to 2020 increased by 15.9%, going up from 715.2 to 828.7 deaths per 100,000 people, according to the report. The early data showed that the top 10 leading causes of death in 2020 were:
Researchers at the National Center for Health Statistics analyzed death certificate data from the National Vital Statistics System, taking a close look at deaths among US residents between January and December of 2020.
COVID-19 was the third leading underlying cause of death in 2020, replacing suicide as one of the top 10 leading causes of death," the researchers wrote in the report. Suicide previously was the 10th leading cause of death but was bumped off the list for 2020 as deaths due to Covid-19 climbed.
The researchers found in their report that about 3.36 million deaths occurred last year. Covid-19 was reported as the underlying cause or a contributing cause of death for nearly 378,000 - or about 11.3% - of those deaths. The data showed heart disease caused 690,882 deaths and cancer caused 598,932 deaths.
The data also showed, overall, death rates were highest among the Black and Native American or Alaska Native communities, adults ages 85 and older and men. The Covid-19 death rate specifically was highest among Hispanics, according to the CDC report. The data are provisional - and so numbers and death rates might change as additional information is received. Since investigating causes of death takes time, final data for a given year are typically published about 11 months after the end of the calendar year.
Seth Rubenstein, executive director of US & Canada at Multimedia Care said business leaders, managers, coaches, influencers of all kinds should be encouraging their audiences to wear masks until further notice from the experts. He adds public safety mandates from government officials shouldn’t even be necessary.
“Any temporary inconveniences we may experience from properly wearing masks in public, along with washing hands, avoiding the exchange of air with non-family members, and getting vaccinated, are all minor in comparison to the potential far-reaching good that comes from such incredibly simple gestures," Rubenstein said. "We should be encouraging all messages that help us remember — please, pandemic responsibly."
The 2024 Asembia Meeting is Underway
April 29th 2024GLP-1s, artificial intelligence and the Inflation Reduction Act are among the topics featured in the education sessions of the specialty pharmacy meeting in Las Vegas. The keynote speaker is William McRaven, a retired four-star admiral and former chancellor of the University of Texas system.
Read More
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
April 27th 2024This week, the FDA has approved several products, including Beqvez, the second gene therapy hemophilia B; Ojemda for children with brain tumors; an additional indication for Lutathera for adolescents with neuroendocrine tumors; and a bladder cancer immunotherapy. The agency has also issued a complete response letter for pz-cel to treat epidermolysis bullosa.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen